Search results for " innovation" in Articles / App Notes
Article
Strategizing for Rapid Changeovers in Biologics Manufacturing
Emergent’s Baltimore Bayview facility, which is the company’s pandemic response facility designated as a Center for Innovation in Advanced Development and Manufacturing (CIADM) by the US Department of…
Article
Improving mAb Manufacturing Productivity by Optimizing Buffer and Media Prep Process Flow
Continuing innovations in single-use technologies, process analytical technologies, and in-line dilution will offer the potential for further significant benefits in the future.
Acknowledgments
…
Article
Challenges in Cell Harvesting Prompt Enhancements
The need to address this bottlenecking issue drives innovations in cell harvesting techniques, including innovations in centrifugation and filtration techniques/equipment. Among the innovations are co…
Article
FDA Framework Spurs Advanced Therapies
To support the innovation pursued by responsible product developers, he believes FDA must “advance a modern, efficient, and least burdensome framework that recognizes the breakneck speed of advancemen…
Article
From Darwin to Recombinant Fc Multimers
In addition, a poster session allowed for an open discussion around some of the latest trends and innovations within the industry in combination with excellent networking opportunities. This year, PPB…
Article
Biopharma in 2016: Higher Quality Drugs, Less Expensive Manufacturing
President Trump has promised to repeal and replace the Affordable Care Act (ACA), but what impact might this have on biosimilar development? As part of the ACA, the Biologics Price Competition and Inn…
Article
A Q&A with Eric Langer: CMOs Embrace New Technology
In our 13th Annual Report of Biomanufacturing, of the 21 areas of innovation tested, we found CMOs more interested in: chromatography, single-use probes and sensors, disposable chromatography, instrum…
Article
CMOs Continue to Improve Overall Biomanufacturing Performance
CMOs note that downstream innovation is the leading way to avoid future capacity constraints. Spending projections aren’t quite as buoyant for downstream innovation, though they are solid. In 2015, 6 …
Article
Monoclonal Antibodies Key to Unlocking the Biosimilars Market
The biosimilars market, many analysts believe, is on the cusp of significant growth. This growth in large part is due to the fact that numerous monoclonal antibody (mAb) biosimilars are expect…
Article
Brazil Emerges as Global Biopharm Collaborator
The country is eying production and innovation, relying on the key support of the government. According to industry associations, biopharmaceutical innovation in Brazil will increase in the future as …